Riktkurs.nu
EN | SV
Stockholm Stock Exchange
Biogaia
+10.26% (12.10)
+10.26% (12.10)
SEBDNB CarnegieCarnegieHandelsbankenHandelsbanken Capital Markets

Latest Target

+10.26%
130.00 SEK

Three Month Consensus

+10.26%
130.00 SEK

All Price Targets For Biogaia

SEB
SEB
Apr 2
130.00 SEK
+10.26%
DNB Carnegie
140.00 SEK
+18.74%
Carnegie
Carnegie
Feb -25
160.00 SEK
+35.71%
Handelsbanken
175.00 SEK
+48.43%
Handelsbanken Capital Markets
130.00 SEK
+10.26%

About The Company

Biogaia AB is a Swedish biotechnology company that develops and sells probiotic products. Biogaia has been developed from research findings on the lactic acid bacterium Limosilactobacillus reuteri and the substance reuterin, which was carried out by Walter Dobrogosz and Sven Lindgren in the 1980s.
Wikipedia